CalcimycinTemefosAbortifacient AgentsAbortifacient Agents, NonsteroidalAbortifacient Agents, SteroidalAbrinAbscisic AcidNerve AgentsAtaxinsAlarminsDermal FillersInterleukin-33S100A12 ProteinAtaxin-1Ataxin-2Ataxin-3Ataxin-7Ataxin-10RNA Recognition Motif ProteinsELAV-Like Protein 2ELAV-Like Protein 3ELAV-Like Protein 4ELAV-Like Protein 1Whey ProteinsPoly(ADP-ribose) Polymerase InhibitorsCELF ProteinsCELF1 ProteinAdenylyl Cyclase InhibitorsSerine-Arginine Splicing FactorsAripiprazoleAlbumin-Bound PaclitaxelLubiprostoneDarbepoetin alfaEfavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug CombinationBevacizumabRisedronic AcidFluticasone-Salmeterol Drug CombinationFluticasoneSalmeterol XinafoateEverolimus
allowableQualifier
Calcimycin/pharmacokineticsTemefos/pharmacokineticsAbortifacient Agents/pharmacokineticsAbortifacient Agents, Nonsteroidal/pharmacokineticsAbortifacient Agents, Steroidal/pharmacokineticsAbrin/pharmacokineticsAbscisic Acid/pharmacokineticsNerve Agents/pharmacokineticsAtaxins/pharmacokineticsAlarmins/pharmacokineticsDermal Fillers/pharmacokineticsInterleukin-33/pharmacokineticsS100A12 Protein/pharmacokineticsAtaxin-1/pharmacokineticsAtaxin-2/pharmacokineticsAtaxin-3/pharmacokineticsAtaxin-7/pharmacokineticsAtaxin-10/pharmacokineticsRNA Recognition Motif Proteins/pharmacokineticsELAV-Like Protein 2/pharmacokineticsELAV-Like Protein 3/pharmacokineticsELAV-Like Protein 4/pharmacokineticsELAV-Like Protein 1/pharmacokineticsWhey Proteins/pharmacokineticsPoly(ADP-ribose) Polymerase Inhibitors/pharmacokineticsCELF Proteins/pharmacokineticsCELF1 Protein/pharmacokineticsAdenylyl Cyclase Inhibitors/pharmacokineticsSerine-Arginine Splicing Factors/pharmacokineticsAripiprazole/pharmacokineticsAlbumin-Bound Paclitaxel/pharmacokineticsLubiprostone/pharmacokineticsDarbepoetin alfa/pharmacokineticsEfavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/pharmacokineticsBevacizumab/pharmacokineticsRisedronic Acid/pharmacokineticsFluticasone-Salmeterol Drug Combination/pharmacokineticsFluticasone/pharmacokineticsSalmeterol Xinafoate/pharmacokineticsEverolimus/pharmacokinetics
hasQualifier
annotation
subhead only; with exogenous c ...... .8.53; DF: /pharmacokin or /PK
@en
broaderQualifier
dateCreated
1987-04-18
dateEstablished
1988-01-01
dateRevised
2015-07-01
historyNote
88; used with Category D 1988 forward
@en
identifier
onlineNote
search policy: Online Manual; ...... arch /pharmacokinetics 1966-87
@en
preferredConcept
preferredTerm
treeNumber
type
label
pharmacokinetics
@en